viernes, 9 de agosto de 2024

Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00215-9/abstract?utm_campaign=update-laninf&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_laninf&_hsenc=p2ANqtz-9UfF1GzIsYUJUFr8i9QNIy5M59iSRdk_914-TVlSgA8nFVyFtjpZNTAO8oU2OXD1KmML5FLlKb3TCqoNJXwOPHLJRHbQ&_hsmi=318965042&utm_content=318125887&utm_source=hs_email

No hay comentarios:

Publicar un comentario